4:05 PM ET
10-Q
Financial Results
Propanc Biopharma Q1 2026 Results: Net Loss of $8.59M, Loss Widens
Propanc Biopharma reported a net loss of $8.6 million for the quarter ended September 30, 2026, compared to a $4.8 million loss in the prior year, driven largely by a significant increase in compensation and professional expenses. The company's cash position decreased to $258,366 from $832,006 at the start of the fiscal year, though it raised $2 million through the exercise of Series C warrants.
- Key figure
- Net loss $8.59M